VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012

Jun 26, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-05-09

Reporting Person: Silva Paul M (SVP & Corp Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-09	Common Stock	I	1483	$60.35	Disposed	0	Indirect
2012-05-18	Common Stock	S	839	$61.15	Disposed	6125	Direct